Dr. Gregory Franz is a board-certified oncologist and hematologist in Jackson, Tennessee. He received his medical degree from University of Rochester School of Medicine and has been in practice for more than 20 years. He is also a Cornell EHMA alumnus.
Almost done! Check your email to get your password.
Bringing New Science to Market
Innovation, Adoption, and Health Policy Challenges
Thursday, June 22, 2023, 1pm EDT
Event Overview
Medical innovation is tackling emerging challenges and reaching new heights every year. So what does the future of health look like? And what health innovations can we expect in the coming decade?
This Keynote will touch on promising health advances as well as the challenges that industry leaders have encountered in market access and adoption, with a focus on areas such as clinical trial design, pricing, and the practical impact of the Inflation Reduction Act. We will discuss potential solutions to these challenges and their long-ranging impact on healthcare with experts including Professor Sean Nicholson, director of Cornell University's Sloan Program in Health Administration; Wyatt Gotbetter, senior vice president and worldwide head of Parexel Access Consulting; and Dr. Gregory Franz, hematologist and medical oncologist at the Kirkland Cancer Center.
This Keynote will touch on promising health advances as well as the challenges that industry leaders have encountered in market access and adoption, with a focus on areas such as clinical trial design, pricing, and the practical impact of the Inflation Reduction Act. We will discuss potential solutions to these challenges and their long-ranging impact on healthcare with experts including Professor Sean Nicholson, director of Cornell University's Sloan Program in Health Administration; Wyatt Gotbetter, senior vice president and worldwide head of Parexel Access Consulting; and Dr. Gregory Franz, hematologist and medical oncologist at the Kirkland Cancer Center.
What You'll Learn
- The types of innovations poised to have the greatest potential impact on health over the next decade
- The challenges faced by companies in bringing innovations to market
- The way the medical community approaches the adoption of new drugs and technologies
- The impact of the Inflation Reduction Act on innovation decisions in the biotech and pharma industries
Speakers
Gregory B. Franz
Community Hematology and Medical Oncology Physician, Medical Director-Optum, Medical Oncology: Cancer & Specialty Guidance Program
West Tennessee Healthcare
Community Hematology and Medical Oncology Physician, West Tennessee Healthcare
Sean Nicholson
Professor
Cornell Jeb E. Brooks School of Public Policy
Professor, Department of Economics, and Director of the Sloan Program in Health Administration, Cornell Brooks School of Public Policy,
Sean Nicholson is a professor in the Department of Policy Analysis and Management (PAM) at Cornell University, the director of the Sloan Program in Health Administration, and a research associate at the National Bureau of Economic Research. Prior to joining the PAM department in 2004, Professor Nicholson was a faculty member in the Health Care Systems Department at The Wharton School of the University of Pennsylvania. He worked for four years as a management consultant with APM and taught high school for two years before enrolling in graduate school. Professor Nicholson received a B.A. from Dartmouth College in 1986 and a Ph.D. in economics from the University of Wisconsin-Madison in 1997.
Wyatt Gotbetter
Senior VP / Worldwide Head
Parexel Access Consulting
Senior VP / Worldwide Head of Parexel Access Consulting
Wyatt Gotbetter is a seasoned life sciences executive and strategy consulting leader experienced in asset and franchise growth strategy and mergers and acquisitions/ transaction advisory support. He received his B.S. in Policy Analysis from Cornell University, as well as his MPA degree and Sloan Certificate focusing on health policy. Mr. Gotbetter has served as an Executive-in-Residence and speaker for Sloan and Brooks courses.
Mr. Gotbetter currently leads the Market Access and Health Economics business for global CRO Parexel, where he was previously a partner for consulting subsidiary Health Advances. Prior to this, he was with Boston Consulting Group (BCG) and the head of New Product Commercialization for Biogen, and he led reimbursement for U.S. commercial payers for medtech leader Boston Scientific. Mr. Gotbetter has led domestic and global teams in marketing strategy, portfolio management, new product commercialization, and market access. He offers expertise in strategy development, life cycle management, valuation, diligence, and digital health, and he has advised or supported integration of more than $40B in life sciences transactions. Mr. Gotbetter is also an independent board member of Diceros Therapeutics.
Gregory B. Franz
Community Hematology and Medical Oncology Physician, Medical Director-Optum, Medical Oncology: Cancer & Specialty Guidance Program
West Tennessee Healthcare
Community Hematology and Medical Oncology Physician, West Tennessee Healthcare
Dr. Gregory Franz is a board-certified oncologist and hematologist in Jackson, Tennessee. He received his medical degree from University of Rochester School of Medicine and has been in practice for more than 20 years. He is also a Cornell EHMA alumnus.
Sean Nicholson
Professor
Cornell Jeb E. Brooks School of Public Policy
Professor, Department of Economics, and Director of the Sloan Program in Health Administration, Cornell Brooks School of Public Policy,
Sean Nicholson is a professor in the Department of Policy Analysis and Management (PAM) at Cornell University, the director of the Sloan Program in Health Administration, and a research associate at the National Bureau of Economic Research. Prior to joining the PAM department in 2004, Professor Nicholson was a faculty member in the Health Care Systems Department at The Wharton School of the University of Pennsylvania. He worked for four years as a management consultant with APM and taught high school for two years before enrolling in graduate school. Professor Nicholson received a B.A. from Dartmouth College in 1986 and a Ph.D. in economics from the University of Wisconsin-Madison in 1997.
Wyatt Gotbetter
Senior VP / Worldwide Head
Parexel Access Consulting
Senior VP / Worldwide Head of Parexel Access Consulting
Wyatt Gotbetter is a seasoned life sciences executive and strategy consulting leader experienced in asset and franchise growth strategy and mergers and acquisitions/ transaction advisory support. He received his B.S. in Policy Analysis from Cornell University, as well as his MPA degree and Sloan Certificate focusing on health policy. Mr. Gotbetter has served as an Executive-in-Residence and speaker for Sloan and Brooks courses.
Mr. Gotbetter currently leads the Market Access and Health Economics business for global CRO Parexel, where he was previously a partner for consulting subsidiary Health Advances. Prior to this, he was with Boston Consulting Group (BCG) and the head of New Product Commercialization for Biogen, and he led reimbursement for U.S. commercial payers for medtech leader Boston Scientific. Mr. Gotbetter has led domestic and global teams in marketing strategy, portfolio management, new product commercialization, and market access. He offers expertise in strategy development, life cycle management, valuation, diligence, and digital health, and he has advised or supported integration of more than $40B in life sciences transactions. Mr. Gotbetter is also an independent board member of Diceros Therapeutics.
- View slide #1
- View slide #2
- View slide #3
View Keynote by completing the form below.
Gain access to this free event
Thanks,
You're Registered!
You're Registered!
Join or sign in to tailor your experience and earn CEUs from Cornell.
Create Account